Herpes Vaccine Candidate Moves Closer To Human Trials

Herpes is one of the most prevalent viruses in humans, but this may not always be the case. Last week, researchers from The University of Pennsylvania reported their most recent success in plans to develop a herpes vaccine. The goal is for this vaccine to work similarly to that currently used to prevent HPV infections, and thus significantly lower the prevalence of herpes infections in future populations.